DS-1471a
Phase 1Terminated 1 views this week 0 watching💤 Quiet
Interest: 21/100
21
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Advanced Solid Tumor
Conditions
Advanced Solid Tumor
Trial Timeline
Aug 4, 2023 → Jul 29, 2025
NCT ID
NCT06074705About DS-1471a
DS-1471a is a phase 1 stage product being developed by Daiichi Sankyo for Advanced Solid Tumor. The current trial status is terminated. This product is registered under clinical trial identifier NCT06074705. Target conditions include Advanced Solid Tumor.
What happened to similar drugs?
16 of 20 similar drugs in Advanced Solid Tumor were approved
Approved (16) Terminated (1) Active (4)
Hype Score Breakdown
Clinical
6
Activity
0
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT06074705 | Phase 1 | Terminated |
Competing Products
20 competing products in Advanced Solid Tumor